Clinical Trial Update: Aminophylline and Contrast Induced Nephropathy in Acute Myocardial Infarction [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluating aminophylline for preventing contrast-induced nephropathy in patients with acute myocardial infarction has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Kidney Injury
• Myocardial Infarction

Drugs mentioned

• Aminophylline (aminophylline)

Snippet

Sponsor: Ospedale Misericordia e Dolce | Conditions: Acute Kidney Injury | Phase 4 | Status: COMPLETED